Thermo Fisher Scientific (TMO) Business News

Track Thermo Fisher Scientific in real time with a live news feed covering Thermo Fisher Scientific stock news, official press releases, company announcements, and an archive of historical Thermo Fisher Scientific news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

TMO Fairly Valued by DCF at $478

GuruFocus

7:30 AM | Monday | Jul 13, 2026

news photo
Loading...

On July 13, 2026, we present a detailed DCF analysis for Thermo Fisher Scientific Inc (TMO), a company currently priced at $527.05. Despite a year-to-date decli

Read full article redirect
7:30 AM | Monday | Jul 13, 2026

TMO Fairly Valued by DCF at $478

GuruFocus

On July 13, 2026, we present a detailed DCF analysis for Thermo Fisher Scientific Inc (TMO), a company currently priced at $527.05. Despite a year-to-date decli

Read full article arrow
News Thumbnail
11:29 AM | Thursday | Jul 9, 2026

Thermo Fisher Q2 Preview: Buy Before The Recovery

Seeking Alpha

Thermo Fisher Scientific Inc. is down 12.2% YTD, underperforming both the S&P 500 and the healthcare sector. Key risks include NIH funding uncertainty, China weakness, slow organic recovery, and integration risk from the $8.9B Clario acquisition.
TMO trades at an 18% discount to its 5-year average P/E, reflecting much of the downside already priced in.

Read full article arrow
News Thumbnail
8:30 AM | Tuesday | Jul 7, 2026

Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches

Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. The law enforcement milestone makes Thermo Fisher's Rapid DNA workflow on the RapidHIT ID™ System the first eligible to generate DNA profiles that can be searched against the n.

Read full article arrow
News Thumbnail
11:32 AM | Thursday | Jul 2, 2026

Arcturus Picks Thermo Fisher To Support Cystic Fibrosis Therapy

Benzinga

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is collaborating with Thermo Fisher Scientific Inc. (NYSE:TMO) to support the Phase 3 development and potential commercialization of ARCT-032, the company's investigational messenger RNA therapy for cystic fibrosis.

Read full article arrow
News Thumbnail
8:00 AM | Wednesday | Jul 1, 2026

Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026

Business Wire

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2026 before the market opens on Thursday, July 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET.
During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the “Investors” section of our website, www.thermofish.

Read full article arrow
News Thumbnail
4:07 AM | Monday | Jun 29, 2026

genedrive shares climb 8% on Thermo Fisher pharmacogenetic testing deal

Proactive Investors

genedrive PLC (AIM:GDR, FRA:D6M) has signed a collaboration agreement with Thermo Fisher Scientific, sending its shares up 8% to 1.4p. The point-of-care pharmacogenetic testing company will develop a high-throughput laboratory test under the deal.

Read full article arrow
News Thumbnail
8:30 AM | Monday | Jun 22, 2026

Thermo Fisher Scientific Showcases New Capabilities Across Manufacturing, Clinical Development and AI-Enabled Research at BIO International 2026

Business Wire

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will showcase new capabilities, strategic investments and initiatives at BIO International 2026 that are helping pharma and biotech customers advance innovation, simplify complex workflows and bring therapies to patients faster. Spanning AI-enabled research, clinical development and advanced manufacturing, these investments reinforce Thermo Fisher's role as a trusted strategic provider of integrated.

Read full article arrow
News Thumbnail
8:30 AM | Monday | Jun 1, 2026

Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026

Business Wire

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today expanded its suite of Thermo Scientific™ Orbitrap™ mass spectrometry platforms, AI-enabled software and integrated workflows at the American Society for Mass Spectrometry (ASMS) Conference. Across research, biopharma and applied testing, scientists face increasingly complex samples, expanding data sets and greater pressure to deliver confident answers faster. Thermo Fisher helps solve that.

Read full article arrow
News Thumbnail
10:25 AM | Friday | May 29, 2026

Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains?

Zacks Investment Research

Thermo Fisher (TMO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Read full article arrow
News Thumbnail
5:13 PM | Thursday | May 28, 2026

Thermo Fisher Scientific Inc (TMO) Stock Up 6.8% and Still Undervalued -- GF Score: 83/100

GuruFocus

On May 28, 2026, Thermo Fisher Scientific Inc (TMO) shares rose 6.8% today, now trading at $487.22. The stock's performance remains volatile with a 52-week rang

Read full article arrow
News Thumbnail